Selected Publications: Tuberculosis

1.            O'Donnell MR, Padayatchi N, Wolf A, Zelnick J, Daftary A, Orrell C, et al. Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients With Multidrug-Resistant Tuberculosis and HIV/AIDS. J Acquir Immune Defic Syndr. 2022;90(3):325-32.

2.            Perumal R, Bionghi N, Nimmo C, Letsoalo M, Cummings MJ, Hopson M, et al. Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2023;62(6).

3.            O'Donnell MR, Larsen MH, Brown TS, Jain P, Munsamy V, Wolf A, et al. Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing. Antimicrob Agents Chemother. 2019;63(4).

4.            Rajagopalan S, Rourke AK, Asare E, Kohlerschmidt DJ, Das L, Ngema SL, et al. Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates. J Infect Dis. 2025;231(4):859-70.